Back to results
US 2026/0256732 A1Published application
Composition for improving relaxation
AssigneeCytoSolve, Inc.
InventorsV. A. Shiva AYYADURAI, Prabhakar DEONIKAR
Life of this patent
Estimating the term…
Abstract
The present disclosure is related to dietary supplements including compositions that include, one or more agents that increase γ-aminobutyric acid (GABA) binding with GABA-A receptor, increase serotonin concentrations, decrease dopamine concentrations, increase brain derived neurotrophic factor (BDNF), decrease cortisol concentrations, increase anandamide (AEA) concentrations and decrease IL-7 & IL-17 concentrations, responsible for improving relaxation.
Claims8
1-19. (canceled)
A composition, comprising:
- about 20% to about 40% w/w of kaempferol;
- about 0.5% to about 10% w/w of hypericin;
- about 2% to about 10% w/w of withanone;
- about 10% to about 30% w/w of ursolic acid;
- about 10% to about 30% w/w of oleanic acid;
- and
- about 10% to about 30% w/w of catechin.
4 more elements
Dependencies are inferred from the claim text.